ProPhase Labs News

Latest ProPhase Labs Stock News & PRPH Headlines

Comparing ProPhase Labs (NASDAQ:PRPH) and Aurora Cannabis (NASDAQ:ACB)

a month ago | defenseworld.net

Critical Contrast: ProPhase Labs (NASDAQ:PRPH) & Takeda Pharmaceutical (NYSE:TAK)

a month ago | defenseworld.net

ProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average – What’s Next?

7 months ago | defenseworld.net

ProPhase Labs (NASDAQ:PRPH) Stock Crosses Below 200 Day Moving Average – What’s Next?

7 months ago | defenseworld.net

ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform

7 months ago | globenewswire.com

ProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average – Time to Sell?

8 months ago | defenseworld.net

ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity

8 months ago | globenewswire.com

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative

9 months ago | globenewswire.com

ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture

10 months ago | globenewswire.com

ProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

10 months ago | defenseworld.net

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

PRPH

ProPhase Labs

$ 0.004870

5.87%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

ProPhase Labs News

Latest ProPhase Labs Stock News & PRPH Headlines

Download App

People Also Watch

Explore our Tools